These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 7957574)

  • 1. Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment.
    Hayashi Y; Haneji N; Hamano H; Yanagi K
    Eur J Immunol; 1994 Nov; 24(11):2826-31. PubMed ID: 7957574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice.
    Haneji N; Hamano H; Yanagi K; Hayashi Y
    J Immunol; 1994 Sep; 153(6):2769-77. PubMed ID: 8077681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of Sjögren's syndrome-like autoimmune lesions in MRL/lpr mice.
    Hayashi Y; Haneji N; Hamano H
    Pathol Int; 1994 Aug; 44(8):559-68. PubMed ID: 7952145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
    Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
    Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Burns WH; Prendergast RA
    Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):246-50. PubMed ID: 8550330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions.
    Jabs DA; Enger C; Prendergast RA
    Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):371-80. PubMed ID: 1993589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of autoimmune exocrinopathy resembling Sjögren's syndrome in adoptively transferred mice with autoreactive CD4+ T cells.
    Arakaki R; Ishimaru N; Saito I; Kobayashi M; Yasui N; Sumida T; Hayashi Y
    Arthritis Rheum; 2003 Dec; 48(12):3603-9. PubMed ID: 14674013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
    Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
    Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
    Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
    Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligoclonality of T cells in salivary glands of autoimmune MRL/lpr mice.
    Skarstein K; Holmdahl R; Johannessen AC; Jonsson R
    Immunology; 1994 Apr; 81(4):497-501. PubMed ID: 8039804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of caspase cascade on the development of primary Sjögren's syndrome.
    Hayashi Y; Arakaki R; Ishimaru N
    J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective treatment of a mouse model of Sjögren's syndrome with eyedrop administration of anti-CD4 monoclonal antibody.
    Hayashi Y; Ishimaru N; Arakaki R; Tsukumo S; Fukui H; Kishihara K; Shiota H; Yasutomo K; Hayashi Y
    Arthritis Rheum; 2004 Sep; 50(9):2903-10. PubMed ID: 15457459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Lee B; Burek CL; Saboori AM; Prendergast RA
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exocrinopathy resembling Sjögren's syndrome induced by a murine retrovirus.
    Suzuki K; Makino M; Okada Y; Kinoshita J; Yui R; Kanazawa H; Asakura H; Fujiwara M; Mizuochi T; Komuro K
    Lab Invest; 1993 Oct; 69(4):430-5. PubMed ID: 8231110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the T cell antigen receptor V beta gene products in labial salivary glands from patients with primary Sjögren's syndrome.
    Roncin S; Guillevin L; Beaugrand M; Vallet S; Pennec YL; Colin J; Youinou P
    Ann Med Interne (Paris); 1995; 146(4):226-8. PubMed ID: 7653939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigations of various animal models for Sjögren's syndrome].
    Hayashi Y
    Nihon Rinsho; 1995 Oct; 53(10):2383-8. PubMed ID: 8531342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine models of Sjögren's syndrome. Immunohistologic analysis of different strains.
    Jabs DA; Prendergast RA
    Invest Ophthalmol Vis Sci; 1988 Sep; 29(9):1437-43. PubMed ID: 3047079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.
    Jabs DA; Lee B; Whittum-Hudson JA; Prendergast RA
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):826-31. PubMed ID: 10711700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association of V beta 8+ T cells with lupus-like syndrome in MRL-lpr/lpr mice.
    Fossati L; Merino R; Iwamoto M; Lemoine R; Izui S
    Eur J Immunol; 1994 Jul; 24(7):1717-20. PubMed ID: 8026533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD3+ T cells in severe combined immunodeficiency (scid) mice. IV. Graft-vs.-host resistance of H-2d scid mice to intravenous injection of allogeneic H-2b (C57BL/6) spleen cells.
    Claesson MH; Rudolphi A; Tscherning T; Reimann J
    Eur J Immunol; 1991 Sep; 21(9):2057-62. PubMed ID: 1832384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.